Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima-city, Kagoshima 890-0065, Japan.
Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.
Comp Biochem Physiol C Toxicol Pharmacol. 2024 Mar;277:109835. doi: 10.1016/j.cbpc.2024.109835. Epub 2024 Jan 11.
Flavin-containing monooxygenases (FMOs) are a family of important drug oxygenation enzymes that, in humans, consist of five functional enzymes (FMO1-5) and a pseudogene (FMO6P). The tree shrew is a non-rodent primate-like species that is used in various biomedical studies, but its usefulness in drug metabolism research has not yet been investigated. In this study, tree shrew FMO1-6 cDNAs were isolated and characterized by sequence analysis, tissue expression, and metabolic function. Compared with human FMOs, tree shrew FMOs showed sequence identities of 85-90 % and 81-89 %, respectively, for cDNA and amino acids. Phylogenetic analysis showed that each tree shrew and human FMO were closely clustered. The genomic and genetic structures of the FMO genes were conserved in tree shrews and humans. Among the five tissue types analyzed (lung, heart, kidney, small intestine, and liver), FMO3 and FMO1 mRNAs were most abundant in liver and kidney, respectively. Recombinant tree shrew FMO1-6 proteins expressed in bacterial membranes all mediated benzydamine and trimethylamine N-oxygenations and methyl p-tolyl sulfide S-oxygenation. The selective human FMO3 substrate trimethylamine was predominantly metabolized by tree shrew FMO3. Additionally, tree shrew FMO6 was active toward trimethylamine, as is cynomolgus macaque FMO6, in contrast with the absence of activity of the human FMO6P pseudogene product. Tree shrew FMO1-6, which are orthologous to human FMOs (FMO1-5 and FMO6P) were identified, and tree shrew FMO3 has functional and molecular features generally comparable to those of human FMO3 as the predominant FMO in liver.
黄素单加氧酶(FMOs)是一类重要的药物氧化酶,在人类中由 5 种功能性酶(FMO1-5)和一个假基因(FMO6P)组成。树鼩是一种非啮齿类灵长类动物,被用于各种生物医学研究,但它在药物代谢研究中的用途尚未得到研究。在这项研究中,通过序列分析、组织表达和代谢功能,分离和鉴定了树鼩 FMO1-6 cDNA。与人类 FMOs 相比,树鼩 FMOs 的 cDNA 和氨基酸序列同一性分别为 85-90%和 81-89%。系统发育分析表明,每只树鼩和人类 FMO 都紧密聚集在一起。FMO 基因的基因组和遗传结构在树鼩和人类中是保守的。在所分析的 5 种组织类型(肺、心脏、肾脏、小肠和肝脏)中,FMO3 和 FMO1 mRNA 在肝脏和肾脏中最为丰富。在细菌膜中表达的重组树鼩 FMO1-6 蛋白均介导了苯佐卡因和三甲胺 N-氧化以及甲基对甲苯磺酰 S-氧化。选择性的人 FMO3 底物三甲胺主要由树鼩 FMO3 代谢。此外,树鼩 FMO6 对三甲胺具有活性,就像食蟹猴 FMO6 一样,而人类 FMO6P 假基因产物则没有活性。鉴定了与人类 FMOs(FMO1-5 和 FMO6P)同源的树鼩 FMO1-6,并且树鼩 FMO3 具有与人类 FMO3 相似的功能和分子特征,是肝脏中主要的 FMO。